CART-immune-related adverse events after BCMA CAR-T therapy.

Paruzzo L, Ho M, Noll JH, Garfall AL, Cohen AD, Fraietta JA, Ruella M

DOI: 10.1016/j.omton.2026.201274
Published: 2026 Sep 17
Container: Molecular therapy. Oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.omton.2026.201274,
  title = {CART-immune-related adverse events after BCMA CAR-T therapy.},
  author = {Paruzzo L and Ho M and Noll JH and Garfall AL and Cohen AD and Fraietta JA and Ruella M},
  year = {2026},
  journal = {Molecular therapy. Oncology},
  doi = {10.1016/j.omton.2026.201274},
  url = {https://doi.org/10.1016/j.omton.2026.201274}
}

RIS

TY  - JOUR
TI  - CART-immune-related adverse events after BCMA CAR-T therapy.
AU  - Paruzzo L
AU  - Ho M
AU  - Noll JH
AU  - Garfall AL
AU  - Cohen AD
AU  - Fraietta JA
AU  - Ruella M
PY  - 2026
JO  - Molecular therapy. Oncology
DO  - 10.1016/j.omton.2026.201274
UR  - https://doi.org/10.1016/j.omton.2026.201274
ER  -

APA

L, P., M, H., JH, N., AL, G., AD, C., JA, F., & M, R. (2026). CART-immune-related adverse events after BCMA CAR-T therapy.. Molecular therapy. Oncology. https://doi.org/10.1016/j.omton.2026.201274

Source records

pubmed · retrieved 2026-09-25T07:06:02.634Z